Phathom Pharmaceuticals, Inc. PHAT Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $175.11M+217% | $55.25M+8,001% | $682K— | $0— | ||
| $22.6M+183% | $7.97M+4,674% | $167K— | $0— | ||
| $152.51M+223% | $47.28M+9,080% | $515K— | $0— | ||
| 87.1%+1.5pp | 85.6%+10.1pp | 75.5%— | —— | ||
| $32.78M-3.8% | $34.08M-31.7% | $49.9M-30.2% | $71.44M-1.2% | ||
| $279.72M-3.8% | $290.66M+146% | $117.93M+16.8% | $101M— | ||
| $312.5M-3.8% | $324.75M+93.5% | $167.83M-2.7% | $172.44M+27.7% | ||
| -$159.99M+42.3% | -$277.47M-65.8% | -$167.31M+3.0% | -$172.44M-27.7% | ||
| -91.4%+411pp | -502.2%+24,030pp | -24,532.6%— | —— | ||
| $68.12M-5.4% | $72.01M+71.6% | $41.97M+53.7% | $27.31M+302% | ||
| -$61.26M-7.7% | -$56.86M-65.9% | -$34.28M-35.6% | -$25.28M-187% | ||
| -$221.25M+33.8% | -$334.33M-65.8% | -$201.59M-2.0% | -$197.72M-37.4% | ||
| -126.3%+479pp | -605.1%+28,954pp | -29,558.9%— | —— | ||
| -$3.04+42.6% | -$5.30-34.5% | -$3.94+22.0% | -$5.05-29.8% | ||
| -$159.35M+42.4% | -$276.67M-65.9% | -$166.74M+3.0% | -$171.82M-27.7% | ||
| -91%+410pp | -500.7%+23,947pp | -24,448.2%— | —— | ||
| -$159.99M+42.3% | -$277.47M-65.8% | -$167.31M+3.0% | -$172.44M-27.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s revenue?
- Phathom Pharmaceuticals, Inc. (PHAT) generated $204.9M in revenue over the trailing twelve months, up 150.3% year over year.
- Is Phathom Pharmaceuticals, Inc. profitable?
- Phathom Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $157.3M over the trailing twelve months, a -76.8% net margin.
- What are Phathom Pharmaceuticals, Inc.'s profit margins?
- Gross margin is 84.9% and operating margin is -47.1%, with a -76.8% net margin.
- What is Phathom Pharmaceuticals, Inc.'s earnings per share?
- Phathom Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-2.10.
- Where does Phathom Pharmaceuticals, Inc.'s income statement data come from?
- Every line is extracted from Phathom Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
